The Impact of Light, Electrical, and Magnetic Neuroregulation Interventions on Sleep-wake Disorders

Launched by SECOND AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY · Jan 22, 2025

Keywords

ClinConnect Summary

This clinical trial is exploring how different types of treatments can help people with sleep disorders, specifically insomnia, narcolepsy, and REM sleep behavior disorder. The researchers will use methods like light therapy and electrical or magnetic stimulation to see how these interventions can improve sleep patterns. The goal is to develop new and effective ways to help those struggling with these conditions.

To participate in the trial, individuals aged 21 to 39 who have been diagnosed with one of the sleep disorders mentioned are encouraged to sign up. However, those with certain serious neurological or mental health issues, recent substance abuse problems, or other significant health conditions may not be eligible. Participants can expect to take part in studies where they will receive these innovative treatments and help researchers understand their effects on sleep. This trial is currently recruiting, so it's a great opportunity for those seeking new options for managing their sleep disorders.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • - Patients with insomnia, narcolepsy,and RBD that have been clearly diagnosed by specialists should sign the informed consent form.
• Exclusion Criteria:
• • 1. Patients with major neurological diseases such as multi-infarct dementia, Huntington\'s disease, normal pressure hydrocephalus, brain tumors, progressive supranuclear palsy, epilepsy, subdural hematoma, multiple sclerosis, or those who have sustained neurological dysfunction or known structural brain abnormalities after significant head trauma are excluded.
• • 2. A history of major depressive disorder or bipolar disorder within the past year, as defined in DSM-IV criteria. A history of schizophrenia (meeting DSM-IV criteria).
• • 3. History of severe drug or alcohol abuse within the past year;
• • 4. Any significant systemic illness or unstable medical condition that may make it difficult to comply with the protocol, such as severe autoimmune diseases or a history of cancer.
• • 5. Have significant hearing, visual, or cognitive impairments, or are unable to participate in interviews in a meaningful way.